LEXARIA BIOSCIENCE CORP. Malpractice Loss Contingency, Discount Rate
LEXARIA BIOSCIENCE CORP. (LEXX) reported Malpractice Loss Contingency, Discount Rate of 7.25% for the 3-month period ending 2024-11-30, per its 10-Q filed 2025-01-10.
Financial Statements › Notes
us-gaap:MalpracticeLossContingencyDiscountRate · last filed 2025-01-10
- LEXARIA BIOSCIENCE CORP. malpractice loss contingency, discount rate for the quarter ending 2024-11-30 was 7.25%, a 0.00% change year-over-year.
- LEXARIA BIOSCIENCE CORP. malpractice loss contingency, discount rate for the quarter ending 2023-11-30 was 7.25%, a 0.00% change year-over-year.
- LEXARIA BIOSCIENCE CORP. malpractice loss contingency, discount rate for the quarter ending 2022-11-30 was 7.25%.
- LEXARIA BIOSCIENCE CORP. malpractice loss contingency, discount rate for fiscal 2023 was 7.25%, a 0.00% change from fiscal 2022.
- LEXARIA BIOSCIENCE CORP. malpractice loss contingency, discount rate for fiscal 2022 was 7.25%.
| Period end | Malpractice Loss Contingency, Discount Rate 3 month | Malpractice Loss Contingency, Discount Rate 6 month | Malpractice Loss Contingency, Discount Rate 9 month | Malpractice Loss Contingency, Discount Rate 12 month |
|---|---|---|---|---|
| 2024-11-30 | 7.25% 10-Q · filed 2025-01-10 | |||
| 2024-08-31 | 7.25% 10-Q · filed 2025-01-10 | |||
| 2024-05-31 | 7.25% 10-Q · filed 2024-07-12 | |||
| 2024-02-29 | 7.25% 10-Q · filed 2024-04-09 | |||
| 2023-11-30 | 7.25% 10-Q · filed 2024-01-12 | |||
| 2023-08-31 | 7.25% 10-K · filed 2024-11-26 | |||
| 2022-11-30 | 7.25% 10-Q · filed 2024-01-12 | |||
| 2022-08-31 | 7.25% 10-K · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |